期刊文献+

TLR/IL-1信号的负性调控因子在IBD中的作用

下载PDF
导出
摘要 近年来TLR信号在IBD肠道炎症中的正性作用已被广泛研究,但是TLR信号转导的负性调节因子在IBD发病中作用的研究少有报道。本文就TLR家族及其配体、传导通路及负性调节因子在IBD中的作用做一综述。
作者 陈彦霞 谢勇
出处 《江西医药》 CAS 2010年第7期712-715,共4页 Jiangxi Medical Journal
基金 国家自然科学基金30860109
  • 相关文献

参考文献1

二级参考文献13

  • 1James D, Gary R, Robert B, et al. An open-label trial of the PPAR gamma ligand rosiglitazone for active ulcerative colitis.Am J Gastroenterol,2001,96 : 3323-3328.
  • 2Sutherland L, Martin F, Greer S, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigrooiditis and proctitis. Gastroenterology, 1987,92 : 1894-1898.
  • 3Daynes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol, 2002,2:748-759.
  • 4Dubuquoy L, Jansson EA, Deeb S, et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis.Gastroenterology ,2003,124 : 1265-1276.
  • 5Meier C, Chicheportiche R, Juge-Aubry C, et al. Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma. Cytokines, 2002,18 : 320-328.
  • 6Gosset P, Charbonnier AS, Delerive P, et al. Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocytederived dendritic cells. Eur J Immunol,2001,31:2857-2865.
  • 7Bassaganya-Riera J, Reynolds K, Martino-Catt S, et al . Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease.Gastroenterology, 2004, 127:777-791.
  • 8Katayama K, Wada K, Nakajima A, et al. A novel PPAR gamma gene therapy to control inflammatory associated with inflammatory bowel disease in a murine model. Gastroenterology, 2003, 124:1315-1324.
  • 9Sanchez-Hidalgo M, Martin AR, Villegas I, et al. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Biochem Pharmacol, 2005,69 : 1733-1744.
  • 10Lytle C ,Tod T, Kathy T, et al. The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency. Inflamm Bowel Dis, 2005, 11: 231-243.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部